Mohamed Elgamaly

Mohamed Elgamaly is a graduate of the Faculty of Pharmacy, Ain Shams University, Egypt. He began his professional career as a Research and Development formulator in the pharmaceutical industry, specialising in the design and optimisation of generic drug formulations. His PhD research is supervised by Abhay Pandit and is funded by the European Union as part of the Nanobeat project. It focuses on the development of nanobiomaterial-based hydrogels to restore cardiac conductivity in atrial fibrillation and left bundle branch block.